DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20161030

Scorpion sting envenomation, Vijayapur, Karnataka, India experience: new observations

Mallanagouda M. Patil, Bhavana Lakhkar, Shankargouda V. Patil, Aravind S. Akki, Raghavendra H. Gobbur, Siddarameshwar S. Kalyanshettar

Abstract


Background: Scorpion sting is a very common problem in rural areas of Vijayapur. Financial status of people and non-availability of antivenin are concerns. The present study enumerates risk factors and experience of using drug Prazosin hydrochloride (Prazosin) at higher initial dose (80-90 microgram/kg) in scorpion sting envenomation.

Methods: A retrospective study was carried out at Shri BM Patil Medical College Hospital and Research Centre Vijayapur Karnataka during the period of September 2014 to August 2015. Case records of 40 cases of scorpion sting envenomation were reviewed. Risk factors were correlated with outcome. Effect of accidental administration of high dose of Prazosin was studied.

Results: Local pain, profuse sweating, vomiting, cold extremities were common presentations. Six patients had myocarditis and one had neurological involvement. One patient was brought dead. Age of patient, time interval between symptoms and treatment, use of steroids and other drugs were main risk factors. High dose Prazosin reduced the time for first response (p= <0.001), total recovery time (p= <0.001), Pediatric Intensive Care Unit stay (p= <0.001) and use of inotropes (P=0.042).

Conclusions: High dose Prazosin is useful and safe in severe cases of scorpion sting envenomation in the resource poor settings.


Keywords


Scorpion sting, Prazosin, Risk factors

Full Text:

PDF

References


Mahadevan S. Scorpion sting. Indian Paediatr. 2000;37:504-13.

Bawaskar HS, Bawaskar PH. Utility of scorpion antivenom Vs Prazosin in the management of severe Mesobuthus Tamulus envenovenoming at a rural setting. J Assoc Physicians India. 2007;55:14-21.

Curry SC, Vance VV, Rayan PJ. Envenomation by the scorpion Centuroids Sculparatus. J Toxicol. 1983-84;21:417-49.

Chowell G, Hyman JM, Diaz-Duenas. Predicting scorpion sting incidence in an endemic region using climatological variables. Int J environ health res. 2005:15:426-35.

Pol R, Vanaki R, Pol Manaswini. The clinical profile and the efficacy of Prazosin in scorpion sting envenomation in children of North Karnataka (India). Journal of clinical and diagnostic research. 2011;5(3):456-8.

Chippaux JP. Emerging options for management of scorpion stings. Drug Des Devel Ther. 2012;(6):165-73.

Bawaskar HS, Bawaskar PH. Scorpion sting: Update. JAPI. 2012;60:46-55.

Devarbhavi PK, Vasudeva MCR. Scorpion sting envenomation-An overview. J Clin Biomed Sci. 2013;3(4):159-66.

Ismail M, Abd-Elsam MA. Are the toxicological effects of scorpion envenomation related to tissue venom concentration? Toxicon. 1988;233-56.

Reddy BRC. Scorpion envenomation what is new? Available as www.apiindia.org/medicine_update _2013/chp93pdf.

Sarkar S, Bhattacharya P, Paswan A. Cerebrovascular manifestations and alteration of coagulation profile in scorpion sting: a case series. Indian j Crit Care. 2008;12:15-7.

Prasad R, Mishra OP, Pandey N, Singh TB. Scorpion sting envenomation in children: factors affecting the outcome. Indian J Pediatr. 2011;78(5):544-8.

Bouaziz M, Bahloul M, Herga FL. Factors associated with pulmonary edema in severe scorpion sting patients a multivariate analysis of 428 cases. Clinical toxicology (Phil). 2006;44:293-300.

Udaykumar N, Rajendra C, Srinivasan AV. Cerebrovascular manifestations in scorpion sting: A case series. Indian J Med Sci. 2006;60:241-4.

Bawaskar HS, Bawaskar PH. Clinical profile of severe scorpion envenomation in children at rural setting. Indian Pediatr. 2003;40(11):1072-5.

Bahloul M, Imen C, Chaari A. Scorpion envenomation among children: Clinical manifestations and outcome (analysis of 685 Cases). Am J trop Hyg. 2010;83(5):1084-92.